CERo Therapeutics (CERO) Stock Chart & Stock Price History → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free CERO Stock Alerts $0.93 -0.03 (-3.13%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends CERo Therapeutics Stock Price Performance5 Day Performance-11.43%1 Month Performance-32.61%3 Month Performance-68.58% Receive CERO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. CERO Stock Chart for Sunday, June, 2, 2024 CERO Chart by TradingView CERo Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.96$0.93-3.12%$0.99$0.9154,667 shs$14.01 million05/30/2024$0.97$0.96-1.30%$1.04$0.9516,862 shs$14.46 million05/29/2024$1.05$0.97-7.37%$1.08$0.9755,394 shs$14.65 million05/28/2024$0.92$1.05+14.40%$1.09$0.94139,645 shs$15.81 million05/27/2024$0.92$0.92$0.96$0.8764,600 shs$13.82 million05/24/2024$0.94$0.92-2.37%$0.96$0.8764,440 shs$13.82 million Get the Latest News and Ratings for CERO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.99$0.94-5.04%$1.03$0.9476,781 shs$13.84 million05/22/2024$1.02$0.99-2.94%$1.05$0.9761,106 shs$14.57 million05/21/2024$1.06$1.02-3.77%$1.06$1.0147,157 shs$15.01 million05/20/2024$1.10$1.06-3.64%$1.10$1.0362,475 shs$15.61 million05/17/2024$1.13$1.10-2.65%$1.17$1.0860,817 shs$16.19 million05/16/2024$1.14$1.13-0.88%$1.17$1.1130,146 shs$16.64 million05/15/2024$1.14$1.14+0.40%$1.18$1.1323,826 shs$16.78 million05/14/2024$1.16$1.14-2.11%$1.20$1.10105,432 shs$16.72 million05/13/2024$1.19$1.16-2.52%$1.20$1.1349,422 shs$17.08 million05/10/2024$1.15$1.19+3.48%$1.23$1.1534,744 shs$17.52 million05/09/2024$1.23$1.15-6.50%$1.26$1.1386,560 shs$16.93 million05/08/2024$1.30$1.23-5.38%$1.31$1.2166,682 shs$18.11 million05/07/2024$1.35$1.30-3.70%$1.38$1.2430,260 shs$19.14 million05/06/2024$1.38$1.35-2.17%$1.42$1.3050,227 shs$19.87 million05/03/2024$1.38$1.38$1.43$1.3542,166 shs$20.31 million05/02/2024$1.38$1.38$1.43$1.3564,839 shs$20.31 million05/01/2024$1.39$1.38-0.72%$1.47$1.3794,274 shs$20.31 million04/30/2024$1.39$1.39$1.71$1.37609,976 shs$20.47 million04/29/2024$1.37$1.39+1.46%$1.40$1.3440,428 shs$20.46 million04/26/2024$1.41$1.37-2.84%$1.47$1.3786,403 shs$20.17 million04/25/2024$1.46$1.41-3.15%$1.50$1.4073,320 shs$20.76 million04/24/2024$1.35$1.46+7.84%$1.49$1.35263,829 shs$21.43 million04/23/2024$1.42$1.35-4.93%$1.42$1.33107,838 shs$19.87 million04/22/2024$1.50$1.42-5.33%$1.52$1.4091,028 shs$20.90 million04/19/2024$1.54$1.50-2.60%$1.58$1.4172,251 shs$22.08 million04/18/2024$1.66$1.54-7.23%$1.72$1.53121,866 shs$22.67 million04/17/2024$1.81$1.66-8.29%$1.78$1.6558,587 shs$24.44 million04/16/2024$1.75$1.81+3.43%$1.84$1.7279,586 shs$26.64 million04/15/2024$1.78$1.75-1.69%$1.85$1.73105,518 shs$25.76 million04/12/2024$1.87$1.78-4.81%$1.94$1.73104,828 shs$11.13 million04/11/2024$1.96$1.87-4.59%$1.96$1.83170,106 shs$11.69 million04/10/2024$2.09$1.96-6.22%$2.08$1.85170,612 shs$12.25 million04/09/2024$1.91$2.09+9.42%$2.13$1.87680,247 shs$13.06 million04/08/2024$1.74$1.91+9.77%$1.96$1.75208,127 shs$11.94 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/05/2024$1.94$1.74-10.31%$1.97$1.70397,057 shs$10.88 million04/04/2024$2.00$1.94-3.00%$2.02$1.87152,986 shs$12.13 million04/03/2024$2.21$2.00-9.50%$2.23$1.81502,817 shs$12.50 million04/02/2024$2.77$2.21-20.22%$2.55$2.07697,958 shs$13.80 million04/01/2024$3.07$2.77-9.77%$3.76$2.445.30 million shs$17.31 million03/29/2024$3.07$3.07$3.34$1.6222.74 million shs$19.19 million03/28/2024$1.63$3.07+88.34%$3.32$1.6223.85 million shs$19.19 million03/27/2024$1.72$1.63-5.23%$1.72$1.6272,646 shs$10.18 million03/26/2024$1.77$1.72-2.82%$1.85$1.55110,257 shs$10.75 million03/25/2024$2.06$1.77-14.08%$2.10$1.74241,837 shs$11.06 million03/22/2024$2.17$2.06-5.07%$2.20$2.05130,005 shs$12.87 million03/21/2024$2.18$2.17-0.46%$2.24$2.06158,332 shs$13.56 million03/20/2024$2.40$2.18-9.17%$2.40$2.16281,002 shs$13.63 million03/19/2024$2.10$2.40+14.29%$2.76$2.02494,163 shs$15 million03/18/2024$2.15$2.10-2.33%$2.15$2.00151,962 shs$13.13 million03/15/2024$2.24$2.15-4.02%$2.24$2.00258,163 shs$13.44 million03/14/2024$2.41$2.24-7.05%$2.49$2.12180,050 shs$14 million03/13/2024$2.66$2.41-9.40%$2.67$2.39355,892 shs$15.06 million03/12/2024$2.90$2.66-8.28%$3.25$2.54638,015 shs$16.61 million03/11/2024$3.95$2.90-26.58%$3.45$2.811.27 million shs$18.13 million03/08/2024$3.08$3.95+28.25%$4.50$3.3311.53 million shs$24.67 million03/07/2024$2.55$3.08+20.78%$10.66$2.8617.36 million shs$19.25 million03/06/2024$2.60$2.55-1.92%$2.80$2.551,367 shs$15.94 million03/05/2024$2.58$2.60+0.78%$2.88$2.554,392 shs$16.25 million03/04/2024$2.96$2.58-12.84%$2.97$2.4510,515 shs$16.13 million03/01/2024$2.95$2.96+0.34%$3.36$2.717,727 shs$18.50 million Related Companies: CLRC Stock Price Chart VSAC Stock Price Chart AQU Stock Price Chart HUDA Stock Price Chart BREZ Stock Price Chart DHAC Stock Price Chart MARX Stock Price Chart AOGO Stock Price Chart VSTE Stock Price Chart WINV Stock Price Chart Receive CERO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CERO) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.